Kangmei Pharma | 600518 - Sales Revenues

Stock Price
1.93
Daily Change
0.02 1.05%
Monthly
0.52%
Yearly
-9.39%
Q1 Forecast
1.85

Kangmei Pharma reported CNY1.37B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 18.42M 14K Jun/2025
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Genomma Lab Internacional MXN 4.02B 620M Dec/2025
Hypermarcas BRL 2.23B 73.31M Sep/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Jiangsu Hengrui CNY 7.43B 1.17B Sep/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sh Fosun Pharma CNY 9.88B 125.79M Sep/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Wuxi Apptec CNY 11.53B 390M Sep/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025